Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arie Belldegrun
Biotech
Belldegrun's VC firm nabs a major $825M funding well
Belldegrun’s third fund for Vida Venture, Vida III, has reeled in a massive $825 million.
Ben Adams
Jun 24, 2021 7:15am
Ginkgo lands on NYSE via $2.5B SPAC merger
May 11, 2021 8:10am
IconOVir uncloaks with $77M, ex-Forty Seven CEO
Jan 5, 2021 6:00am
ASCO: Allogene's off-the-shelf CAR-T shows hints of efficacy
May 13, 2020 5:00pm
Allogene chair Belldegrun reveals he has COVID-19
Mar 16, 2020 7:45am
Allogene names ex-Adaptimmune exec Amado as CMO
Aug 5, 2019 10:12am